10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 272 filers reported holding 10X GENOMICS INC in Q2 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $8,728,737 | +53.1% | 156,457 | 0.0% | 3.04% | +53.0% |
| Q4 2022 | $5,701,293 | +29.2% | 156,457 | +1.0% | 1.99% | +6.9% |
| Q3 2022 | $4,413,000 | -37.1% | 154,942 | 0.0% | 1.86% | -43.3% |
| Q2 2022 | $7,011,000 | -40.5% | 154,942 | 0.0% | 3.28% | -27.4% |
| Q1 2022 | $11,786,000 | -48.9% | 154,942 | 0.0% | 4.53% | -43.4% |
| Q4 2021 | $23,080,000 | +2.5% | 154,942 | +0.2% | 8.00% | -1.9% |
| Q3 2021 | $22,507,000 | -18.6% | 154,603 | +9.4% | 8.16% | -18.2% |
| Q2 2021 | $27,661,000 | -3.7% | 141,258 | -11.0% | 9.97% | -14.4% |
| Q1 2021 | $28,735,000 | +20.3% | 158,758 | -5.9% | 11.65% | +13.0% |
| Q4 2020 | $23,896,000 | +17.3% | 168,758 | +3.3% | 10.31% | +6.6% |
| Q3 2020 | $20,368,000 | +15.8% | 163,366 | -17.0% | 9.67% | +8.3% |
| Q2 2020 | $17,589,000 | +36.0% | 196,938 | -5.1% | 8.94% | +16.3% |
| Q1 2020 | $12,936,000 | – | 207,578 | – | 7.68% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 708,528 | $29,226,780 | 100.00% |
| Meritech Capital Associates V L.L.C. | 494,236 | $20,387,235 | 6.48% |
| Sands Capital Ventures, LLC | 481,770 | $19,873,013 | 5.88% |
| Decheng Capital Management III (Cayman), LLC | 359,554 | $14,831,603 | 4.95% |
| Iron Triangle Partners LP | 666,945 | $27,511,481 | 4.02% |
| Endurant Capital Management LP | 71,044 | $2,930,565 | 2.63% |
| Brown Capital Management | 3,081,105 | $127,095,581 | 1.95% |
| RTW INVESTMENTS, LP | 1,519,956 | $62,698,185 | 1.32% |
| Parametrica Management Ltd | 15,300 | $631,125 | 1.06% |
| Capital Impact Advisors, LLC | 14,821 | $611,366 | 1.02% |